Literature DB >> 15772301

Molecular physiology of urate transport.

Matthias A Hediger1, Richard J Johnson, Hiroki Miyazaki, Hitoshi Endou.   

Abstract

Humans excrete uric acid as the final breakdown product of unwanted purine nucleotides. Urate scavenges potential harmful radicals in our body. However, in conjunction with genetic or environmental (especially dietary) factors, urate may cause gout, nephrolitiasis, hypertension, and vascular disease. Blood levels of urate are maintained by the balance between generation and excretion. Excretion requires specialized transporters located in renal proximal tubule cells, intestinal epithelial cells, and vascular smooth muscle cells. The recently identified human urate transporters URAT1, MRP4, OAT1, and OAT3 are thought to play central roles in homeostasis and may prove interesting targets for future drug development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772301     DOI: 10.1152/physiol.00039.2004

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  88 in total

1.  Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

Authors:  Kate Witkowska; Kyla M Smith; Sylvia Y M Yao; Amy M L Ng; Debbie O'Neill; Edward Karpinski; James D Young; Christopher I Cheeseman
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

2.  Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization.

Authors:  M J Gold; P R Hiebert; H Y Park; D Stefanowicz; A Le; M R Starkey; A Deane; A C Brown; G Liu; J C Horvat; Z A Ibrahim; M B Sukkar; P M Hansbro; C Carlsten; S VanEeden; D D Sin; K M McNagny; D A Knight; J A Hirota
Journal:  Mucosal Immunol       Date:  2015-10-28       Impact factor: 7.313

3.  Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers.

Authors:  Masanobu Sato; Takashi Iwanaga; Hideaki Mamada; Toshio Ogihara; Hikaru Yabuuchi; Tomoji Maeda; Ikumi Tamai
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

Review 4.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

6.  Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and non-stone-forming controls.

Authors:  Vernon M Pais; Ross P Holmes; Dean G Assimos
Journal:  J Endourol       Date:  2007-02       Impact factor: 2.942

7.  Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.

Authors:  J Vázquez-Mellado; V Alvarado-Romano; R Burgos-Vargas; A L Jiménez-Vaca; G Pozo-Molina; S A Cuevas-Covarrubias
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

Review 8.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

Review 9.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 10.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.